1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow ARX788: new trials by email Literature Review of ARX788 trials Research Report on ARX788
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01) ARX788 - Breast Neoplasms, Gastric Neoplasm | Phase 1 | Completed | Ambrx, Inc. | 106 | 2018-03-20 | 2024-02-01 |
| A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression ARX788 - Breast Neoplasms, Stomach Neoplasms | Phase 1 | Terminated | Zhejiang Medicine Co., Ltd. | 9 | 2016-03-01 | 2020-06-05 |
Breast Neoplasms (2) · Stomach Neoplasms (2)
Ambrx, Inc. (1) · Zhejiang Medicine Co., Ltd. (1)
Australia (2) · New Zealand (1) · United States (1)